Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -10.80% | -10.80% | +290.55% |
05-15 | Perspective Therapeutics Swings to Loss in Q1, Revenue Rises | MT |
05-14 | RBC Starts Perspective Therapeutics With Outperform Rating, $3 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+290.55% | 1.03B | |
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+9.65% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+21.57% | 25.29B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- B. Riley Starts Perspective Therapeutics With Buy Rating, $1.20 Price Target; Says Well-Positioned to Break Out of Biotech Pack